Atai Beckley NV (ATAI)

• Market cap: $1.41B
• 1 day: 3.73%
• 5 days: 6.58%
• 1 month: -34.73%
• 3 months: -16.34%
• 6 months: 68.4%
• Year to date: 143.13%
• 1 year: 118.54%
• 5 years: -80%
• 10 years: -80%
• Sector: Healthcare
• Industry: Biotechnology

About: Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.

Employees: 54